National flu report summary: 17 October 2019 (week 42)
Updated 1 October 2020
1. Main points: data up to week 41, 2019
Data up to week 41 (ending 13 October 2019) shows:
- during week 41, all influenza activity indicators are below baseline
- the impact of flu on healthcare services is below baseline for hospitalisations and for ICU and HDU influenza admissions
The full weekly flu report this summary is based on, accompanying spreadsheet of data and slideset are available from weekly national flu reports: 2019 to 2020 season.
2. Surveillance scheme summaries
2.1 Community
Data from outbreak surveillance shows:
- there have been 28 new acute respiratory outbreaks reported in the past 7 days
- 28 outbreaks were reported from care homes where 2 tested positive for influenza A(not subtyped)
- 1 outbreaks was from a school with no test results available
- The remaining outbreak was from a hospital with no test results available
2.2 Primary care
Data from primary care surveillance shows:
- the rate of influenza-like illness (ILI) was below baseline threshold level
- the overall weekly ILI GP consultation rate was 5.0 per 100,000 in week 41 compared to 4.3 per 100,000 registered population in the previous week in participating GP practices for England
- in the devolved administrations, ILI rates were below baseline threshold levels for Northern Ireland, Scotland and Wales
2.3 Secondary care
Data from secondary care surveillance shows:
- hospitalisation rate observed was below baseline impact levels, with a rate of 0.30 per 100,000 in week 41 compared to 0.04 per 100,000 trust catchment population in the previous week, for England (17 NHS Trusts)
- ICU and HDU admission rate observed was below baseline impact levels, with a rate of 0.01 per 100,000 in week 41 compared to 0.00 per 100,000 trust catchment population in the previous week, for England (133 out of 143 NHS Trusts)
- there were no influenza admissions reported from the 6 severe respiratory failure centres in the UK
2.4 All-cause mortality
Data from all-cause mortality surveillance shows:
- no statistically significant excess all-cause mortality by week of death was seen overall and by age group in England in week 41
- in the devolved administrations, no statistically significant excess all-cause mortality for all ages was observed in Wales and Northern Ireland in week 41, no data was available for Scotland in week 39 2019
2.5 Microbiological surveillance
Data from microbiological surveillance shows:
- in primary care, three samples tested positive for influenza (1 A(H1N1)pdm09, 1 A(H3) and 1 A(unknown subtype)) through the UK GP sentinel swabbing schemes in week 41
- in secondary care influenza percent positivity was 2.2%, below baseline threshold levels
- a total of 38 detections were recorded through the DataMart scheme (2 influenza A(H1N1)pdm09, 15 influenza A(H3) and 21 influenza A(not subtyped)).
2.6 Vaccination
Data from the GP patient, healthcare worker and primary school-age children flu vaccine uptake programmes shows:
- up to week 41 2019, in 40.7% of GP practices in England, the provisional proportion of people who had received the 2019 to 2020 influenza vaccine in targeted groups was 7.8% in under 65 years in a clinical risk group, 9.1% in pregnant women and 39.4% in those aged 65 and over
- up to week 41 2019, in 40.8% of GP practices reporting for the childhood collection the provisional proportion vaccinated was 0.0% in 2 year olds and 3 year olds respectively
3. International situation
- in the temperate zones of the southern hemisphere, influenza activity was low in most countries, and appeared to decrease in Chile after a second wave of influenza activity of predominately B viruses.
- in the temperate zone of the northern hemisphere, influenza activity remained at inter-seasonal levels in most countries; however activity appeared to have started across the countries of the Arabian Peninsula.
- worldwide, seasonal influenza A viruses continued to account for the majority of detections, though the proportion of influenza B viruses increased in recent weeks
4. Further information
See ‘seasonal influenza: guidance, data and analysis’ for further information on the symptoms, diagnosis, management, surveillance and epidemiology of seasonal influenza (flu).
Further information and guidance on the surveillance schemes PHE use to track seasonal influenza is available.